“CRISPR/Cas9 mediated next generation gene therapy in chronic myeloid leukemia: CRISPR/Cas9 and CML”, Indian J Exp Biol, vol. 63, no. 01, pp. 52–65, Jan. 2025, doi: 10.56042/ijeb.v63i01.7040.